The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hemostatic Sponge-Global Market Insights and Sales Trends 2024
Synopsis
The global Hemostatic Sponge market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hemostatic Sponge in various end use industries. The expanding demands from the Surgical Wound Care and General Wound Care, are propelling Hemostatic Sponge market. Microfibrillar Collagen, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chitosan segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Materials, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hemostatic Sponge, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hemostatic Sponge market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hemostatic Sponge market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hemostatic Sponge sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hemostatic Sponge covered in this report include Bard, Pfizer, Ethicon, Gelita Medical, Equimedical, Biocer, Celox, Hemostasis and MBP, etc.
The global Hemostatic Sponge market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bard
Pfizer
Ethicon
Gelita Medical
Equimedical
Biocer
Celox
Hemostasis
MBP
Medira
Hemotec Medical
Starch Medical
Success Pharmaceutical
Changsha Hairun
Global Hemostatic Sponge market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hemostatic Sponge market, Segment by Materials:
Microfibrillar Collagen
Chitosan
Other
Global Hemostatic Sponge market, by Application
Surgical Wound Care
General Wound Care
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Materials, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hemostatic Sponge manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hemostatic Sponge in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Hemostatic Sponge market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hemostatic Sponge in various end use industries. The expanding demands from the Surgical Wound Care and General Wound Care, are propelling Hemostatic Sponge market. Microfibrillar Collagen, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chitosan segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Materials, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hemostatic Sponge, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hemostatic Sponge market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hemostatic Sponge market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hemostatic Sponge sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hemostatic Sponge covered in this report include Bard, Pfizer, Ethicon, Gelita Medical, Equimedical, Biocer, Celox, Hemostasis and MBP, etc.
The global Hemostatic Sponge market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bard
Pfizer
Ethicon
Gelita Medical
Equimedical
Biocer
Celox
Hemostasis
MBP
Medira
Hemotec Medical
Starch Medical
Success Pharmaceutical
Changsha Hairun
Global Hemostatic Sponge market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hemostatic Sponge market, Segment by Materials:
Microfibrillar Collagen
Chitosan
Other
Global Hemostatic Sponge market, by Application
Surgical Wound Care
General Wound Care
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Materials, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hemostatic Sponge manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hemostatic Sponge in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Hemostatic Sponge Market Overview
1.1 Hemostatic Sponge Product Overview
1.2 Hemostatic Sponge Market Segment by Materials
1.2.1 Microfibrillar Collagen
1.2.2 Chitosan
1.2.3 Other
1.3 Global Hemostatic Sponge Market Size by Materials
1.3.1 Global Hemostatic Sponge Market Size Overview by Materials (2018-2029)
1.3.2 Global Hemostatic Sponge Historic Market Size Review by Materials (2018-2023)
1.3.3 Global Hemostatic Sponge Forecasted Market Size by Materials (2024-2029)
1.4 Key Regions Market Size Segment by Materials
1.4.1 North America Hemostatic Sponge Sales Breakdown by Materials (2018-2023)
1.4.2 Europe Hemostatic Sponge Sales Breakdown by Materials (2018-2023)
1.4.3 Asia-Pacific Hemostatic Sponge Sales Breakdown by Materials (2018-2023)
1.4.4 Latin America Hemostatic Sponge Sales Breakdown by Materials (2018-2023)
1.4.5 Middle East and Africa Hemostatic Sponge Sales Breakdown by Materials (2018-2023)
2 Global Hemostatic Sponge Market Competition by Company
2.1 Global Top Players by Hemostatic Sponge Sales (2018-2023)
2.2 Global Top Players by Hemostatic Sponge Revenue (2018-2023)
2.3 Global Top Players by Hemostatic Sponge Price (2018-2023)
2.4 Global Top Manufacturers Hemostatic Sponge Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hemostatic Sponge Market Competitive Situation and Trends
2.5.1 Hemostatic Sponge Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hemostatic Sponge Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hemostatic Sponge as of 2022)
2.7 Date of Key Manufacturers Enter into Hemostatic Sponge Market
2.8 Key Manufacturers Hemostatic Sponge Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hemostatic Sponge Status and Outlook by Region
3.1 Global Hemostatic Sponge Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hemostatic Sponge Historic Market Size by Region
3.2.1 Global Hemostatic Sponge Sales in Volume by Region (2018-2023)
3.2.2 Global Hemostatic Sponge Sales in Value by Region (2018-2023)
3.2.3 Global Hemostatic Sponge Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hemostatic Sponge Forecasted Market Size by Region
3.3.1 Global Hemostatic Sponge Sales in Volume by Region (2024-2029)
3.3.2 Global Hemostatic Sponge Sales in Value by Region (2024-2029)
3.3.3 Global Hemostatic Sponge Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hemostatic Sponge by Application
4.1 Hemostatic Sponge Market Segment by Application
4.1.1 Surgical Wound Care
4.1.2 General Wound Care
4.2 Global Hemostatic Sponge Market Size by Application
4.2.1 Global Hemostatic Sponge Market Size Overview by Application (2018-2029)
4.2.2 Global Hemostatic Sponge Historic Market Size Review by Application (2018-2023)
4.2.3 Global Hemostatic Sponge Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hemostatic Sponge Sales Breakdown by Application (2018-2023)
4.3.2 Europe Hemostatic Sponge Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Hemostatic Sponge Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Hemostatic Sponge Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Hemostatic Sponge Sales Breakdown by Application (2018-2023)
5 North America Hemostatic Sponge by Country
5.1 North America Hemostatic Sponge Historic Market Size by Country
5.1.1 North America Hemostatic Sponge Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hemostatic Sponge Sales in Volume by Country (2018-2023)
5.1.3 North America Hemostatic Sponge Sales in Value by Country (2018-2023)
5.2 North America Hemostatic Sponge Forecasted Market Size by Country
5.2.1 North America Hemostatic Sponge Sales in Volume by Country (2024-2029)
5.2.2 North America Hemostatic Sponge Sales in Value by Country (2024-2029)
6 Europe Hemostatic Sponge by Country
6.1 Europe Hemostatic Sponge Historic Market Size by Country
6.1.1 Europe Hemostatic Sponge Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hemostatic Sponge Sales in Volume by Country (2018-2023)
6.1.3 Europe Hemostatic Sponge Sales in Value by Country (2018-2023)
6.2 Europe Hemostatic Sponge Forecasted Market Size by Country
6.2.1 Europe Hemostatic Sponge Sales in Volume by Country (2024-2029)
6.2.2 Europe Hemostatic Sponge Sales in Value by Country (2024-2029)
7 Asia-Pacific Hemostatic Sponge by Region
7.1 Asia-Pacific Hemostatic Sponge Historic Market Size by Region
7.1.1 Asia-Pacific Hemostatic Sponge Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hemostatic Sponge Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hemostatic Sponge Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hemostatic Sponge Forecasted Market Size by Region
7.2.1 Asia-Pacific Hemostatic Sponge Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hemostatic Sponge Sales in Value by Region (2024-2029)
8 Latin America Hemostatic Sponge by Country
8.1 Latin America Hemostatic Sponge Historic Market Size by Country
8.1.1 Latin America Hemostatic Sponge Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hemostatic Sponge Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hemostatic Sponge Sales in Value by Country (2018-2023)
8.2 Latin America Hemostatic Sponge Forecasted Market Size by Country
8.2.1 Latin America Hemostatic Sponge Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hemostatic Sponge Sales in Value by Country (2024-2029)
9 Middle East and Africa Hemostatic Sponge by Country
9.1 Middle East and Africa Hemostatic Sponge Historic Market Size by Country
9.1.1 Middle East and Africa Hemostatic Sponge Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hemostatic Sponge Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hemostatic Sponge Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hemostatic Sponge Forecasted Market Size by Country
9.2.1 Middle East and Africa Hemostatic Sponge Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hemostatic Sponge Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bard
10.1.1 Bard Company Information
10.1.2 Bard Introduction and Business Overview
10.1.3 Bard Hemostatic Sponge Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bard Hemostatic Sponge Products Offered
10.1.5 Bard Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Hemostatic Sponge Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer Hemostatic Sponge Products Offered
10.2.5 Pfizer Recent Development
10.3 Ethicon
10.3.1 Ethicon Company Information
10.3.2 Ethicon Introduction and Business Overview
10.3.3 Ethicon Hemostatic Sponge Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Ethicon Hemostatic Sponge Products Offered
10.3.5 Ethicon Recent Development
10.4 Gelita Medical
10.4.1 Gelita Medical Company Information
10.4.2 Gelita Medical Introduction and Business Overview
10.4.3 Gelita Medical Hemostatic Sponge Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Gelita Medical Hemostatic Sponge Products Offered
10.4.5 Gelita Medical Recent Development
10.5 Equimedical
10.5.1 Equimedical Company Information
10.5.2 Equimedical Introduction and Business Overview
10.5.3 Equimedical Hemostatic Sponge Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Equimedical Hemostatic Sponge Products Offered
10.5.5 Equimedical Recent Development
10.6 Biocer
10.6.1 Biocer Company Information
10.6.2 Biocer Introduction and Business Overview
10.6.3 Biocer Hemostatic Sponge Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Biocer Hemostatic Sponge Products Offered
10.6.5 Biocer Recent Development
10.7 Celox
10.7.1 Celox Company Information
10.7.2 Celox Introduction and Business Overview
10.7.3 Celox Hemostatic Sponge Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Celox Hemostatic Sponge Products Offered
10.7.5 Celox Recent Development
10.8 Hemostasis
10.8.1 Hemostasis Company Information
10.8.2 Hemostasis Introduction and Business Overview
10.8.3 Hemostasis Hemostatic Sponge Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Hemostasis Hemostatic Sponge Products Offered
10.8.5 Hemostasis Recent Development
10.9 MBP
10.9.1 MBP Company Information
10.9.2 MBP Introduction and Business Overview
10.9.3 MBP Hemostatic Sponge Sales, Revenue and Gross Margin (2018-2023)
10.9.4 MBP Hemostatic Sponge Products Offered
10.9.5 MBP Recent Development
10.10 Medira
10.10.1 Medira Company Information
10.10.2 Medira Introduction and Business Overview
10.10.3 Medira Hemostatic Sponge Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Medira Hemostatic Sponge Products Offered
10.10.5 Medira Recent Development
10.11 Hemotec Medical
10.11.1 Hemotec Medical Company Information
10.11.2 Hemotec Medical Introduction and Business Overview
10.11.3 Hemotec Medical Hemostatic Sponge Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hemotec Medical Hemostatic Sponge Products Offered
10.11.5 Hemotec Medical Recent Development
10.12 Starch Medical
10.12.1 Starch Medical Company Information
10.12.2 Starch Medical Introduction and Business Overview
10.12.3 Starch Medical Hemostatic Sponge Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Starch Medical Hemostatic Sponge Products Offered
10.12.5 Starch Medical Recent Development
10.13 Success Pharmaceutical
10.13.1 Success Pharmaceutical Company Information
10.13.2 Success Pharmaceutical Introduction and Business Overview
10.13.3 Success Pharmaceutical Hemostatic Sponge Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Success Pharmaceutical Hemostatic Sponge Products Offered
10.13.5 Success Pharmaceutical Recent Development
10.14 Changsha Hairun
10.14.1 Changsha Hairun Company Information
10.14.2 Changsha Hairun Introduction and Business Overview
10.14.3 Changsha Hairun Hemostatic Sponge Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Changsha Hairun Hemostatic Sponge Products Offered
10.14.5 Changsha Hairun Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hemostatic Sponge Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hemostatic Sponge Industrial Chain Analysis
11.4 Hemostatic Sponge Market Dynamics
11.4.1 Hemostatic Sponge Industry Trends
11.4.2 Hemostatic Sponge Market Drivers
11.4.3 Hemostatic Sponge Market Challenges
11.4.4 Hemostatic Sponge Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hemostatic Sponge Distributors
12.3 Hemostatic Sponge Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
